Metall Zug Group: SHL Medical AG plans combined production and office building at Tech Cluster Zug Donnerstag, 12. November 2020 - 06:40

Press release dated 12 November 2020

Zug, 12 November 2020 – Further progress has been made in developing the Tech Cluster Zug. In collaboration with SHL Medical AG, an invitation to submit design and development plans has been launched for the "Südtor" building lot in the south of the Tech Cluster Zug site. The intention is to create a combined production and office building. SHL Medical AG plans to manufacture drug delivery systems for the pharma industry at this site from 2024. As landowner, Urban Assets Zug AG, a subsidiary of Metall Zug AG, will construct the building and rent it out to SHL Medical AG.

SHL Medical is a global player in the design, development and manufacture of advanced drug delivery systems such as autoinjectors, pen injectors, and wearable drug delivery systems. Until now, SHL Medical has combined first-class manufacturing in Asia with global design visions and the strengths of Western management practices to offer clients first-class products and services. SHL Medical has 5,200 employees across its worldwide locations.

In 2018, SHL Medical established its corporate headquarters in Zug (CH) as a means to intensify its global expansion strategy. Building a new site in Zug will fortify SHL Medical’s presence in Europe and put its manufacturing capabilities at the doorstep of the European market. It will also allow SHL Medical to set up greener supply chains.

The V-ZUG Group and Metall Zug Group have shown that running production operations in Switzerland is possible. The Tech Cluster Zug, where V-ZUG is currently investing in modern, digitized production facilities and buildings for the manufacture of household appliances, is also the ideal location for SHL Medical AG to expand its business. In addition, the Tech Cluster Zug with its industrial ecosystem and its focus on sustainability and its future-oriented building and energy supply solutions were a decisive factor in SHL Medical's choice of location.

Therefore, the "Südtor" building lot, the first to be opened up to third parties outside the Metall Zug Group and V-ZUG Group, can now be developed with a preferred partner. V-ZUG AG will move out of the building lot in question as planned over the next two years, as it no longer needs this space. HandwerkStadt Zug will move to the ground floor of the Mobility-Hub Zug. It will then be possible to construct the new office and production building so that SHL Medical can move in on schedule. As landowner, Urban Assets Zug AG, a subsidiary of Metall Zug AG, will construct the building and rent it out to SHL Medical AG.

The winning project in the competition that has now been launched and in which Bauart Architekten und Planer, EM2N Architekten, Graber & Steiger Architekten and Penzel Valier AG have been invited to take part, is likely to be awarded in March 2021.

About the Tech Cluster Zug

The Tech Cluster Zug is being created on V-ZUG AG's main site in the city of Zug and sends out a clear signal about the future of industry in Switzerland. With the intent of strategically transforming the production site, V-ZUG is currently taking steps to modernize its production facilities and concentrate them geographically. This will facilitate the development of an attractive innovation district, where additional industrial enterprises, technology-related services, start-ups, research and educational institutions can take up residence. The project's aim is to create a future-proof urban area that strengthens Zug as a location for industry and positions itself as a sustainable site with building and energy supply solutions that point the way forward.

About SHL Medical

SHL Medical is a world-leading solutions provider in the design, development, and manufacturing of advanced delivery devices such as autoinjectors, pen injectors, and advanced wearable drug delivery systems. It also offers final assembly, labeling, and packaging solutions for its drug delivery devices.

With locations in Switzerland, Taiwan, Sweden, and the US, SHL’s experienced engineers and designers develop product enhancements and breakthrough drug delivery solutions for pharma and biotech clients globally. Significant investments in R&D have enhanced its broad pipeline of next-generation drug delivery systems that support ongoing innovations in drug development and digital healthcare. This includes advanced reusable and disposable injectors that can accommodate high-volume and high-viscosity formulations and can be enhanced through digital implementations.

About the Metall Zug Group

Metall Zug is a group of industrial companies headquartered in Zug. The Group has around 3,000 employees and comprises five Business Units:

• Infection Control (Belimed Group)
• Medical Devices (Haag-Streit Group)
• Wire Processing (Schleuniger Group)
• Technologycluster & Infrastructure (Tech Cluster Zug AG, Urban Assets Zug AG)
• Other (Life Science Solutions (Belimed Life Science AG, Belimed Life Science d.o.o.), Gehrig Group AG and Metall Zug AG)

The holding company Metall Zug AG is listed in the Swiss Reporting Standard of SIX Swiss Exchange in Zurich (type B registered shares: securities number 3982108, ticker symbol METN).

Legal Notes

The expectations expressed in this press release are based on assumptions. Actual results may vary from those anticipated. This press release is published in German and English. The German version is binding. Metall Zug AG processes personal data in accordance with its privacy statement available under: https://www.metallzug.ch/en/datenschutzerklaerung.

Key Dates

Further information

This press release is available at https://www.metallzug.ch/en/medien/medienmitteilungen.